Os TherapiesOSTX
13F holders, Q1 2025 (March 31)6holders +1
2new positions
1sold out
$1.54avg. 13F price*
At the end of Q1 2025, 6 institutions reported holding Os Therapies Inc. (OSTX) in their 13F filings, up 1 from Q4 2024. 2 opened new positions and 1 sold out. The largest holders were CM Management, LLC ($462K), BlackRock, Inc. ($58K) and Ingalls & Snyder LLC ($56K).
- Company
- Os Therapies Inc.
- CUSIP
- 68764Y207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $79K |
| Exits | 1 | $128K |
All 13F filers, Q4 2024 → Q1 2025: 275,996 shares bought and 31,714 shares sold, net +244,282 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| CM Management, LLC | 0.46% | Add +172.6% | 300,000 | $462K |
| BlackRock, Inc. | 0.00% | Add +1093.3% | 37,507 | $58K |
| Ingalls & Snyder LLC | 0.00% | New | 36,676 | $56K |
| Stifel Financial Corp. | 0.00% | New | 15,000 | $23K |
| Armstrong Advisory Group, Inc. | 0.00% | No change | 100 | $428 |
| Morgan Stanley | 0.00% | Reduce -99.8% | 3 | $5 |
"% of holder's portfolio" is OSTX's weight in each manager's 13F, not the share of Os Therapies Inc. the manager owns.